Publications Database

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Arnold L. E. et al. (2000)

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network.

Journal of Autism and Developmental Disorders

April, 30(2), pp. 99–111

Read Abstract (New Window)

Blankenship K. et al. (2010)

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Pediatric Health

4(4), pp. 375-381

Read Abstract (New Window) Read Full (New Window)

Blankenship K. et al. (2011)

Guanfacine, extended, release, two, patients, pervasive, developmental, disorders

Journal of Child and Adolescent Psychopharmacology

21(3), pp. 287-290

Caldwell R. L. et al. (2012)

The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Research in Autism Spectrum Disorders

August, 22(4), pp. 277-283.

Read Abstract (New Window) Read Full (New Window)

Corson A. et al. (2004)

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

Journal of Clinical Psychiatry

65(1), pp. 1531-1536

Read Abstract (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-90.

Read Abstract (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-89.

Read Abstract (New Window)

Erickson C. A. et al. (2007)

A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Psychopharmacology (Berl)

191(1), pp. 141-147

Read Abstract (New Window)

Erickson C. A. et al. (2010)

Aripiprazole in autism spectrum disorders and fragile X syndrome.

Neurotherapeutics

7(3), pp. 258-263

Read Abstract (New Window)

Erickson C. A. et al. (2005)

Gastrointestinal factors in autistic disorder: a critical review.

Journal of Autism and Developmental Disorders

35(6), pp. 713-727

Read Abstract (New Window)

Lindsay R. L. et al. (2006)

Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study.

Journal of Intellectual and Developmental Disability

December, 31(4), pp. 204-209.

Read Abstract (New Window)

McCracken J. T. et al. (2014)

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

Pharmacogenomics

14(3), pp. 295-302.

Read Abstract (New Window) Read Full (New Window)

McCracken J. T. et al. (2002)

Risperidone in children with autism and serious behavioral problems.

New England Journal of Medicine

347(5), pp. 314-321

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)

McDougle C. J. , Kem D. , Posey D. J. (2002)

Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

41(8), pp. 921-927

Read Abstract (New Window)

McDougle C. J. , Kresch L. E. , Posey D. J. (2000)

Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

Journal of Autism and Developmental Disorders

30(5), pp. 427-435

Read Abstract (New Window)